Community-acquired acinetobacter pneumonia

Insights

Acinetobacter calcoaceticus var anitratus can cause severe community-acquired pneumonia, particularly in older adults with chronic conditions. Early appropriate antibiotic therapy is crucial for improving survival rates in these patients.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pulmonology

Background:

  • Acinetobacter calcoaceticus var anitratus is a gram-negative bacillus rarely reported as a cause of community-acquired pneumonia.
  • This study investigates the clinical presentation and outcomes of pneumonia caused by this organism.

Observation:

  • Six new cases of community-acquired, bacteremic pneumonia due to Acinetobacter calcoaceticus var anitratus were identified.
  • The organism appears to be a more frequent cause of community-acquired pneumonia than previously recognized.

Findings:

  • Acinetobacter pneumonia typically affects older individuals with chronic diseases, notably alcoholism.
  • The illness is characterized by rapid onset, respiratory distress, hypoxemia, leukopenia, and shock.
  • Radiographic findings include lobar or bronchopneumonic infiltrates, often becoming bilateral rapidly, with frequent pleural effusions.
  • The mortality rate is high at 43%, with granulocytopenia, empyema, and inappropriate antibiotic therapy predicting fatal outcomes.

Implications:

  • This organism should be considered in the differential diagnosis of severe community-acquired pneumonia, especially in at-risk populations.
  • Prompt and appropriate antibiotic treatment, including carbenicillin and an aminoglycoside, is associated with increased survival.
  • Further research is warranted to understand the pathogenesis and optimize treatment strategies for Acinetobacter pneumonia.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...